Sulforaphane pretreatment prevents systemic inflammation and renal injury in response to cardiopulmonary bypass
Authors:
- 1 August 2014
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 148 (2) , 690-697.e3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Analyses of pig genomes provide insight into porcine demography and evolutionNature, 2012
- Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: Involvement of the MAPK, NF-κB and AP-1 signaling pathwaysVascular Pharmacology, 2012
- Whole Blood Transcriptomics in Cardiac Surgery Identifies a Gene Regulatory Network Connecting Ischemia Reperfusion with Systemic InflammationPLOS ONE, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airwayClinical Immunology, 2009
- Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular DiseaseDiabetes, 2008
- Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathwayBiochemical Pharmacology, 2008
- Differential involvement of NF-κB and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophilsJournal of Leukocyte Biology, 2006
- Signaling to NF-κBGenes & Development, 2004
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002